[FSH and steroid hormone excretion in breast cancer during chemotherapy].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000652:urine; D003520:Cyclophosphamide / Q000627:therapeutic use; D004967:Estrogens / Q000652:urine*; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D005640:Follicle Stimulating Hormone / Q000652:urine*; D005938:Glucocorticoids / Q000652:urine*; D006801:Humans; D008593:Menopause; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011276:Pregnanediol / Q000652:urine*; D013852:Thiotepa / Q000627:therapeutic use; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D004967:Estrogens; D005938:Glucocorticoids; D014747:Vinblastine; D003520:Cyclophosphamide; D005640:Follicle Stimulating Hormone; D013852:Thiotepa; D011276:Pregnanediol; D005472:Fluorouracil; D008727:Methotrexate
Ekskretsiia FSG i steroidnykh gormonov u bol'nykh rakom molochnoi zhelezy pri khimioterapii.